Macitentan;ACT 064992; ACT-064992
-
Molecular Structure
Detailed Description
Macitentan is an orally active, non-peptide dual endothelin (ET)(A) and ET(B) receptor antagonist for the potential treatment of idiopathic pulmonary fibrosis (IPF) and pulmonary arterial hypertension (PAH).
http://www.chemscene.com/Macitentan.html